Korean J Pain.  2017 Apr;30(2):98-103. 10.3344/kjp.2017.30.2.98.

Antinociceptive effect of intrathecal sec-O-glucosylhamaudol on the formalin-induced pain in rats

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, School of Medicine, Chosun University, Gwangju, Korea. mdmole@chosun.ac.kr
  • 2Department of Anesthesiology and Pain Medicine, Chosun University Hospital, Gwangju, Korea.
  • 3Department of Anesthesiology and Pain Medicine, Medical School, Chonnam National University, Gwangju, Korea.
  • 4Department of Premedics, School of Medicine, Chosun University, Gwangju, Korea.

Abstract

BACKGROUND
The root of Peucedanum japonicum Thunb., a perennial herb found in Japan, the Philippines, China, and Korea, is used as an analgesic. In a previous study, sec-O-glucosylhamaudol (SOG) showed an analgesic effect. This study was performed to examine the antinociceptive effect of intrathecal SOG in the formalin test.
METHODS
Male Sprague-Dawley rats were implanted with an intrathecal catheter. Rats were randomly treated with a vehicle and SOG (10 µg, 30 µg, 60 µg, and 100 µg) before formalin injection. Five percent formalin was injected into the hind-paw, and a biphasic reaction followed, consisting of flinching and licking behaviors (phase 1, 0-10 min; phase 2, 10-60 min). Naloxone was injected 10 min before administration of SOG 100 µg to evaluate the involvement of SOG with an opioid receptor. Dose-responsiveness and ED50 values were calculated.
RESULTS
Intrathecal SOG showed a significant reduction of the flinching responses at both phases in a dose-dependent manner. Significant effects were showed from the dose of 30 µg and maximum effects were achieved at a dose of 100 µg in both phases. The ED50 value (95% confidence intervals) of intrathecal SOG was 30.3 (25.8-35.5) µg during phase 1, and 48.0 (41.4-55.7) during phase 2. The antinociceptive effects of SOG (100 µg) were significantly reverted at both phases of the formalin test by naloxone.
CONCLUSIONS
These results demonstrate that intrathecal SOG has a very strong antinociceptive effect in the formalin test and it seems the effect is related to an opioid receptor.

Keyword

Analgesia; Formalin test; Nociception; Opioid receptor; Peucedanum japonicum Thunb.; Sec-O-glucosylhamaudol

MeSH Terms

Analgesia
Animals
Catheters
China
Formaldehyde
Humans
Japan
Korea
Male
Naloxone
Nociception
Pain Measurement
Philippines
Rats*
Rats, Sprague-Dawley
Receptors, Opioid
Formaldehyde
Naloxone
Receptors, Opioid

Figure

  • Fig. 1 Time course after formalin injection shows antinociceptive effects of intrathecal sec-O-glucosylhamaudol (SOG). SOG reduced the flinching responses after formalin injection significantly in a dose dependent manner during both phases. The antinociceptive effect of SOG (100 µg) was significantly reverted at both phases of formalin test by naloxone. Each line represents the mean ± SEM of 6 rats/group.

  • Fig. 2 Dose–response data shows antinociceptive effects of intrathecal sec-O-glucosylhamaudol (SOG). SOG reduced the flinching responses after formalin injection significantly in a dose dependent manner during phase 1 (A) and phase 2 (B). Significant effect was showed from the dose of 30 µg and maximum effect was achieved at a dose of 100 µg both phases. The antinociceptive effect of SOG (100 µg) was significantly reverted at both phases of formalin test by naloxone. Data are presented as the percentage of control. *P < 0.001 vs. control. †P < 0.001 vs. SOG 100 µg.


Cited by  2 articles

Effect of sec-O-glucosylhamaudol on mechanical allodynia in a rat model of postoperative pain
Gi-Ho Koh, Hyun Song, Sang Hun Kim, Myung Ha Yoon, Kyung Joon Lim, Seon-Hee Oh, Ki Tae Jung
Korean J Pain. 2019;32(2):87-96.    doi: 10.3344/kjp.2019.32.2.87.

Sec-O-glucosylhamaudol mitigates inflammatory processes and autophagy via p38/JNK MAPK signaling in a rat neuropathic pain model
Seon Hee Oh, Suk Whee Kim, Dong Joon Kim, Sang Hun Kim, Kyung Joon Lim, Kichang Lee, Ki Tae Jung
Korean J Pain. 2021;34(4):405-416.    doi: 10.3344/kjp.2021.34.4.405.


Reference

1. McCurdy CR, Scully SS. Analgesic substances derived from natural products (natureceuticals). Life Sci. 2005; 78:476–484. PMID: 16216276.
Article
2. Ikeshiro Y, Mase I, Tomita Y. Dihydropyranocoumarins from roots of Peucedanum japonicum. Phytochemistry. 1992; 31:4303–4306.
Article
3. Chen IS, Chang CT, Sheen WS, Teng CM, Tsai IL, Duh CY, et al. Coumarins and antiplatelet aggregation constituents from Formosan Peucedanum japonicum. Phytochemistry. 1996; 41:525–530. PMID: 8821432.
Article
4. Hisamoto M, Kikuzaki H, Ohigashi H, Nakatani N. Antioxidant compounds from the leaves of Peucedanum japonicum thunb. J Agric Food Chem. 2003; 51:5255–5261. PMID: 12926867.
Article
5. Zimecki M, Artym J, Cisowski W, Mazol I, Włodarczyk M, Gleńsk M. Immunomodulatory and anti-inflammatory activity of selected osthole derivatives. Z Naturforsch C. 2009; 64:361–368. PMID: 19678539.
Article
6. Zheng M, Jin W, Son KH, Chang HW, Kim HP, Bae KH, et al. The constituents isolated from Peucedanum japonicum Thunb. and their cyclooxygenase (COX) inhibitory activity. Korean J Med Crop Sci. 2005; 13:75–79.
7. Okuyama E, Hasegawa T, Matsushita T, Fujimoto H, Ishibashi M, Yamazaki M. Analgesic components of saposhnikovia root (Saposhnikovia divaricata). Chem Pharm Bull (Tokyo). 2001; 49:154–160. PMID: 11217101.
Article
8. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983; 16:109–110. PMID: 6877845.
Article
9. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 1976; 17:1031–1036. PMID: 14677603.
Article
10. Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain. 1996; 64:345–355. PMID: 8740613.
Article
11. Tallarida RJ. Drug synergism and dose-effect data analysis. Boca Raton (FL): Chapman & Hall/CRC;2000. p. 57–71.
12. Sarkhail P. Traditional uses, phytochemistry and pharmacological properties of the genus Peucedanum: a review. J Ethnopharmacol. 2014; 156:235–270. PMID: 25193684.
Article
13. Sasaki H, Taguchi H, Endo T, Yosioka I. The constituents of Ledebouriella seseloides Wolff. I. structures of three new chromones. Chem Pharm Bull (Tokyo). 1982; 30:3555–3562.
Article
14. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 1987; 30:103–114. PMID: 3614974.
Article
15. Yoon MH, Park KD, Lee HG, Kim WM, An TH, Kim YO, et al. Additive antinociception between intrathecal sildenafil and morphine in the rat formalin test. J Korean Med Sci. 2008; 23:1033–1038. PMID: 19119449.
Article
16. Nishiyama T. Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test. Eur J Pharmacol. 2000; 395:203–210. PMID: 10812050.
Article
17. Colucci M, Maione F, Bonito MC, Piscopo A, Di Giannuario A, Pieretti S. New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation. Pharmacol Res. 2008; 57:419–425. PMID: 18508278.
Article
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr